STAT+: Top contributors to leading psychiatry journals fail to disclose industry payments, analysis finds
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
Amid ongoing concern over conflicts of interest that may affect medical practice, a new study found that 14% of the $4.5 million paid to authors in two leading psychiatry journals was undisclosed and nearly all of the payments were made to researchers conducting randomized controlled trials for pharmaceuticals.<\/p>\n
All totaled, $206,000 paid to American Journal of Psychiatry authors, or 7.5% of total payments, was not disclosed, while $439,000, or 25% of the payments made to contributors of the Journal of the American Medical Association Psychiatry, was not disclosed.\u00a0Total undisclosed payments among the top 10 highest-earning authors accounted for 85% and 99.6% of all payments that were not disclosed in the AJP and JAMA Psychiatry, respectively.<\/p>\n
Among those who received undisclosed payments, 80% of the authors who contributed to JAMA Psychiatry and 36.3% of those who wrote for AJP received \u201csubstantial\u201d undisclosed payments, defined as those exceeding $5,000, according to the National Institutes of Health threshold for a \u201csignificant financial interest.\u201d<\/p>\n
Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n